Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 20 Mar 2020 |
2 | Reply to Exam Report (MIS-R) | 16 Oct 2020 |
3 | Documents in support of Show cause Hearing (SCH) | 09 Nov 2021 |
4 | Documents in support of Show cause Hearing (SCH) | 13 Jan 2022 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 13 Jan 2022 |
6 | Journal Copy | 08 Jun 2022 |
7 | Certificate | 08 Sep 2022 |
8 | TM-P(SUBSEQUENT PROPRIETOR BY WAY OF ASSIGNMENT OR TRANSFER OF A SINGLE MARK) | 17 Jul 2023 |
9 | Notices | 28 Feb 2024 |
1 | Hearing Notice (Show Cause) | 12091107 | 01 Sep 2021 | |
2 | Hearing Notice (Show Cause) | 12487932 | 17 Nov 2021 | |
3 | Hearing Notice (Show Cause) | 12842401 | 18 Jan 2022 | |
4 | Tribunal Accepted Notice for : 4478662 | 13199676 | 5543936 | 17 Mar 2022 |
5 | Scrutiny Report | 17549447 | 6589495 | 27 Feb 2024 |
The application for Lumise was made on 20 March 2020.
The trademark applicant for Lumise is INDIABULLS PHARMACEUTICALS.
Lumise is applied in class(es) 3.
Application for Lumise is on Registered stage.
Application Id allotted to Lumise is 4478662.
Trademark agent or attorney for the application is M/S. V.A. Associates.
Lumise filed with the Intellectual property office as a WORD.